Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.5K Buy
1,961
+1,549
+376% +$34.6K ﹤0.01% 2327
2026
Q1
$7K Buy
412
+221
+116% +$4.74K ﹤0.01% 3343
2025
Q4
$4.91K Sell
191
-27
-12% -$621 ﹤0.01% 3424
2025
Q3
$4.69K Buy
218
+3
+1% +$68 ﹤0.01% 3293
2025
Q2
$4.73K Buy
215
+84
+64% +$1.84K ﹤0.01% 3429
2025
Q1
$2.93K Hold
131
﹤0.01% 3021
2024
Q4
$2.26K Buy
131
+63
+93% +$978 ﹤0.01% 3062
2024
Q3
$1.14K Buy
68
+36
+113% +$864 ﹤0.01% 3059
2024
Q2
$916 Hold
32
﹤0.01% 3005
2024
Q1
$1.22K Buy
+32
New +$1.21K ﹤0.01% 2814
2023
Q1
Sell
-1,240
Closed -$20K 4154
2022
Q4
$20K Buy
1,240
+131
+12% +$4.74K ﹤0.01% 2886
2022
Q3
$33K Hold
1,109
﹤0.01% 2700
2022
Q2
$33K Hold
1,109
﹤0.01% 2466
2022
Q1
$33K Buy
+1,109
New +$47.5K ﹤0.01% 2466
2021
Q3
Sell
-2,115
Closed -$126K 3435
2021
Q2
$126K Buy
2,115
+1,915
+958% +$108K ﹤0.01% 1121
2021
Q1
$9K Buy
+200
New +$9.34K ﹤0.01% 2180

Other funds holding PGNY

IFP Advisors's PGNY Position: Q2 2026 in Review

IFP Advisors increased its Progyny (PGNY) stake by 376% in Q2 2026, buying an estimated $34.6K and bringing the position to 1,961 shares worth $56.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

IFP Advisors first reported a position in PGNY in Q1 2021 and has held it in 16 quarters since. The position peaked at $126K in Q2 2021. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • IFP Advisors held 1,961 shares of Progyny worth $56.5K as of Q2 2026.
  • IFP Advisors bought 1,549 Progyny shares in Q2 2026, an estimated $34.6K.
  • Progyny made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2327 holding.
  • IFP Advisors first reported a position in Progyny in Q1 2021 and has held it in 16 quarters since.
  • IFP Advisors's Progyny position peaked at $126K in Q2 2021.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.